The quinoline-3-carboxamide anti-angiogenic agent, it, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts it is a quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. it has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts. 
